InvestorsHub Logo

Bx3

Followers 38
Posts 1325
Boards Moderated 0
Alias Born 07/16/2013

Bx3

Re: okaly post# 13469

Tuesday, 10/27/2015 3:37:09 AM

Tuesday, October 27, 2015 3:37:09 AM

Post# of 15766
MSTX, It appears there are so many in force here , to acknowledge your most most recent and excellent work in the area of heart disease. It would appear that Consistency and Patience are your middle names , and in spite of those pure science requirements, you are incessantly ramping up and increasing the spectrum of the MSTX platform's base. What amazing results you continue to exact; it is a constantly spreading horizon , what you have accomplished. And how you have managed to attract so many top line hospitals/ research centers all over the world , for the EPIC study, which is nearing completion. You continue to attack opportunities with which no one can compete. Your latest work on the cardiac vasculature, in and of itself, what research effort can compete with that? As a long term hold subscriber, my focus remains steadfastly on all of these remarkable and timely advances, and MAST's massive contributions to the world of sickle cell disease and the families and children all over the world impacted. Thankyou for providing the excellent reports on your advances. In fact, it is getting difficult to keep up with all of your scientific advances. The international medical community, at large, appears to have every reason to continue to roll out the red carpet for you. Congratulations! Best of luck in your continued success!
All stated is IMHO.